Om detta spel

The newest installment in the Grisaia visual novel series. All of the girls from Mihama, past and present, must face off against a new evil terrorist organization in an all-out war.

This installment of Frontwing's Grisaia series features writing by the author of "ATRI -My Dear Moments-" Asta Konno, who is joining forces with the original writers of the first Grisaia game, "The Fruit of Grisaia", and artwork by Watanabe Akio and many other famous illustrators!

We hope you enjoy the newest game in Frontwing's Grisaia series!


Story

"If you order me to, Master, I'll wipe out all of humanity."

SORD (Social Ops, Research & Development) is an agency that was established to recruit and train talented operatives for special anti-terrorism units. All kinds of misfit girls are enlisted in SORD's training schools. They are issued guns and live ammunition in the name of national defense, for that is the only way they could be granted a place in the world.
Arata is the handler of Class D at Mihama Academy, a school for SORD. Class D is nicknamed "Dead Stock", because it's full of third-rate students. In order to increase his students' chances of survival, Arata trains them using PeTS, an experimental neural signal synchronization technology.

During one extrajudicial mission, he finds a mysterious girl sleeping inside an incubator at a terrorist hideout. As if drawn together by fate, Arata is able to sync with her using PeTS, and the two narrowly escape with their lives. The girl introduces herself as "L", and Arata welcomes her into Class D.

These events trigger the beginning of Class D's fight against the mysterious terrorist organization "Hadeo."

This is a story of girls who, with nowhere else to go, have chosen the path of the gun...

Beskrivning av vuxet innehåll

Utvecklarna beskriver innehållet så här:

This Game may contain content not appropriate for all ages: Strong Violence, Blood, Strong Language, Partial Nudity and Suggestive Themes, Kiss, Comic Mischief, Crude Humor, Mature Humor, Alcohol and Drug References.